Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Inhibition of Telomerase Increases Resistance of Melanoma Cells to Temozolomide, but Not to Temozolomide Combined with Poly (ADP-Ribose) Polymerase Inhibitor

Lucio Tentori, Ilaria Portarena, Marcella Barbarino, Alessandra Balduzzi, Lauretta Levati, Matteo Vergati, Annamaria Biroccio, Barry Gold, Maria Luisa Lombardi and Grazia Graziani
Molecular Pharmacology January 2003, 63 (1) 192-202; DOI: https://doi.org/10.1124/mol.63.1.192
Lucio Tentori
1 2 3 4 5
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ilaria Portarena
1 2 3 4 5
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marcella Barbarino
1 2 3 4 5
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alessandra Balduzzi
1 2 3 4 5
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lauretta Levati
1 2 3 4 5
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matteo Vergati
1 2 3 4 5
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Annamaria Biroccio
1 2 3 4 5
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Barry Gold
1 2 3 4 5
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Luisa Lombardi
1 2 3 4 5
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Grazia Graziani
1 2 3 4 5
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 63 no. 1 192-202
DOI 
https://doi.org/10.1124/mol.63.1.192
PubMed 
12488552

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received August 8, 2002
  • Accepted October 14, 2002
  • Published online January 1, 2003.

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Lucio Tentori1,
  2. Ilaria Portarena1,
  3. Marcella Barbarino1,3,
  4. Alessandra Balduzzi1,5,
  5. Lauretta Levati2,
  6. Matteo Vergati1,
  7. Annamaria Biroccio,
  8. Barry Gold4,
  9. Maria Luisa Lombardi3, and
  10. Grazia Graziani1
  1. 1Department of Neuroscience, University of Rome “Tor Vergata”, Rome, Italy (L.T., I.P., M.B., A.B., M.V., G.G.); 2“Istituto Dermopatico dell'Immacolata”, Istituto di Ricovero e Cura a Carattere Scientifico, Rome, Italy (L.L.); 3Experimental Oncology-Immunology, National Cancer Institute “G. Pascale”, Naples, Italy (M.B., M.L.L.); 4Eppley Institute for Research in Cancer and Allied Diseases and Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, Nebraska (B.G.); and 5Experimental Chemotherapy Laboratory, “Regina Elena” Cancer Institute, Rome, Italy (A.B.)
  1. Grazia Graziani, Department of Neuroscience, University of Rome “Tor Vergata”, Via Montpellier 1, 00133 Rome, Italy. E-mail: graziani{at}uniroma2.it
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: December 2002 to January 2023

AbstractFullPdf
Dec 2002252723
Jan 2003912882
Feb 200364929
Mar 2003104724
Apr 2003104634
May 200373411
Jun 200343322
Jul 2003123622
Aug 2003122511
Sep 200312218
Oct 2003122114
Nov 2003203711
Dec 200322237
Jan 2004122720
Feb 2004123315
Mar 2004215219
Apr 2004132827
May 2004213811
Jun 2004183116
Jul 20042316223
Aug 2004174335
Sep 200493913
Oct 2004165214
Nov 2004175124
Dec 2004194018
Jan 2005316020
Feb 2005163913
Mar 2005104716
Apr 200541613
May 200593911
Jun 2005123816
Jul 2005113711
Aug 20058168
Sep 20056145
Oct 20059289
Nov 200573011
Dec 2005132913
Jan 2006103213
Feb 200611266
Mar 200632715
Apr 20064153
May 20066158
Jun 20062219
Jul 20067144
Aug 200610129
Sep 20064107
Oct 200633210
Nov 200665213
Dec 200643618
Jan 200751810
Feb 200742414
Mar 200732917
Apr 200794016
May 200731810
Jun 200732117
Jul 200741711
Aug 20079183
Sep 20075164
Oct 20072197
Nov 2007489
Dec 20071107
Jan 200871715
Feb 2008112618
Mar 20088810
Apr 2008597
May 20089126
Jun 2008111811
Jul 2008141611
Aug 20088105
Sep 2008201812
Oct 200851413
Nov 20087115
Dec 2008896
Jan 20094154
Feb 20099164
Mar 200912146
Apr 20094118
May 2009882
Jun 200913135
Jul 20098123
Aug 20097105
Sep 200916128
Oct 200926116
Nov 2009575
Dec 2009656
Jan 20103115
Feb 2010484
Mar 2010644
Apr 201010196
May 20107137
Jun 2010756
Jul 20105118
Aug 20101163
Sep 20107106
Oct 201041515
Nov 201094613
Dec 201041610
Jan 20118268
Feb 2011587
Mar 201161015
Apr 2011338
May 20116911
Jun 2011683
Jul 201110119
Aug 2011558
Sep 201141010
Oct 20111097
Nov 201114125
Dec 201171213
Jan 2012487
Feb 20127109
Mar 201241312
Apr 201251127
May 20129129
Jun 20125911
Jul 2012678
Aug 2012598
Sep 2012586
Oct 201251020
Nov 201241714
Dec 20122713
Jan 201317129
Feb 20137419
Mar 20139615
Apr 2013111919
May 2013497
Jun 2013156
Jul 20132315
Aug 20135411
Sep 2013161116
Oct 2013546
Nov 20138912
Dec 2013518
Jan 2014754
Feb 20141443
Mar 20141033
Apr 201410717
May 201451011
Jun 2014338
Jul 2014753
Aug 2014247
Sep 2014365
Oct 2014796
Nov 20141368
Dec 2014568
Jan 2015324
Feb 2015544
Mar 2015775
Apr 2015182
May 2015788
Jun 20153113
Jul 20155810
Aug 20156115
Sep 2015373
Oct 2015346
Nov 2015356
Dec 2015774
Jan 2016587
Feb 201619813
Mar 201617713
Apr 20161456
May 20161534
Jun 2016479
Jul 20163105
Aug 2016673
Sep 201613106
Oct 20162179
Nov 2016060
Dec 20160112
Jan 20170141
Feb 20170161
Mar 20171153
Apr 20170143
May 20170179
Jun 20170202
Jul 20171212
Aug 20172152
Sep 20174143
Oct 20177123
Nov 20178143
Dec 20178152
Jan 20180141
Feb 20182193
Mar 20181124
Apr 20181312
May 201801305
Jun 20183664
Jul 20182546
Aug 20181122
Sep 20180164
Oct 20182549
Nov 20181877
Dec 201852111
Jan 20194011
Feb 20193000
Mar 20191522
Apr 20191800
May 20191012
Jun 2019902
Jul 20191530
Aug 20191824
Sep 20191200
Oct 20191110
Nov 20191410
Dec 20191420
Jan 20201400
Feb 20202610
Mar 20201500
Apr 2020900
May 2020400
Jun 2020900
Jul 20201100
Aug 2020311
Sep 2020210
Oct 20201610
Nov 2020810
Dec 20201500
Jan 20211710
Feb 2021510
Mar 20211110
Apr 20211521
May 20211721
Jun 2021510
Jul 20211020
Aug 2021710
Sep 2021731
Oct 20211110
Nov 20215420
Dec 2021843
Jan 20221733
Feb 2022820
Mar 2022310
Apr 20221110
May 20221110
Jun 20222011
Jul 20222310
Aug 20223721
Sep 20221600
Oct 20224510
Nov 20223410
Dec 2022510
Jan 2023610

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 63 (1)
Molecular Pharmacology
Vol. 63, Issue 1
1 Jan 2003
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Inhibition of Telomerase Increases Resistance of Melanoma Cells to Temozolomide, but Not to Temozolomide Combined with Poly (ADP-Ribose) Polymerase Inhibitor
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Inhibition of Telomerase Increases Resistance of Melanoma Cells to Temozolomide, but Not to Temozolomide Combined with Poly (ADP-Ribose) Polymerase Inhibitor

Lucio Tentori, Ilaria Portarena, Marcella Barbarino, Alessandra Balduzzi, Lauretta Levati, Matteo Vergati, Annamaria Biroccio, Barry Gold, Maria Luisa Lombardi and Grazia Graziani
Molecular Pharmacology January 1, 2003, 63 (1) 192-202; DOI: https://doi.org/10.1124/mol.63.1.192

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Inhibition of Telomerase Increases Resistance of Melanoma Cells to Temozolomide, but Not to Temozolomide Combined with Poly (ADP-Ribose) Polymerase Inhibitor

Lucio Tentori, Ilaria Portarena, Marcella Barbarino, Alessandra Balduzzi, Lauretta Levati, Matteo Vergati, Annamaria Biroccio, Barry Gold, Maria Luisa Lombardi and Grazia Graziani
Molecular Pharmacology January 1, 2003, 63 (1) 192-202; DOI: https://doi.org/10.1124/mol.63.1.192
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • The binding site for KCI807 in the androgen receptor
  • Fatty acid amide hydrolase in cisplatin nephrotoxicity
  • eCB Signaling System in hiPSC-Derived Neuronal Cultures
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics